ClinicalTrials.gov
ClinicalTrials.gov Menu

Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00032292
Recruitment Status : Completed
First Posted : March 18, 2002
Last Update Posted : March 13, 2012
Sponsor:
Information provided by (Responsible Party):
Facet Biotech

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2006
  Actual Study Completion Date : August 2006